Trials / Completed
CompletedNCT00941057
Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium
Open-label, Randomized, Cross-over Study to Investigate the Bioequivalence of Estradiol Valerate (EV), Dienogest (DNG) and Levomefolate Calcium After Single Oral Administration of a Tablet Formulation Containing 2 mg Estradiol Valerate and 3 mg Dienogest Without and With 0.451 mg Levomefolate Calcium and a Tablet Formulation Containing 0.451 mg Levomefolate Calcium in 42 Healthy Postmenopausal Women
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Investigation of the bioequivalence (BE) of Estradiol Valerate (EV) and Dienogest (DNG) after administration of one film-coated tablet containing 2 mg Estradiol Valerate, 3 mg Dienogest and 0.451 mg Levomefolate calcium as compared to one film-coated tablet containing 2 mg Estradiol Valerate,3 mg Dienogest.Investigation of the bioequivalence of levomefolate calcium after administration of one film-coated tablet containing 2 mg Estradiol Valerate, 3 mg Dienogest and 0.451 mg Levomefolate calcium as compared to one film-coated tablet containing 0.451 mg levomefolate calcium
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium | Oral, single dose, 2 mg EV + 3 mg DNG + 0.451 mg levomefolate calcium washout phase between treatments: at least 7 days |
| DRUG | BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG) | Oral, single dose, 2 mg EV + 3 mg DNG washout phase between treatments: at least 7 days |
| DRUG | BAY 86-7660,levomefolate calcium | Oral, single dose, 0.451 mg levomefolate calcium washout phase between treatments: at least 7 days |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2009-12-01
- Completion
- 2010-01-01
- First posted
- 2009-07-17
- Last updated
- 2016-08-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00941057. Inclusion in this directory is not an endorsement.